OR WAIT null SECS
Plan is to expand capabilities across the drug commercialization process
Medical Knowledge Group, LLC, a marketing and technology-oriented service for companies in the biopharmaceutical industry, has acquired research and consulting firm Magnolia Innovation.
Founded in 2013, Magnolia focuses exclusively on life sciences to help build, launch and redefine biopharmaceutical brands by leveraging market insights and business strategies. The firm is based in Hoboken, NJ.
"Magnolia Innovation's strength in market research complements our robust data analytics capabilities," said Leon Behar, CEO of Medical Knowledge Group. He added that, through the acquisition, his company plans to expand its capabilities across the drug commercialization process.
New York-based Medical Knowledge Group provides biopharmaceutical companies with network-mapping analytics, patient-finding analytics and multi-channel marketing services. It partners with biopharmaceutical companies and niche biotech firms to maximize the commercial potential of their brands.
In January, Medical Knowledge Group was acquired by private equity firm Court Square Capital Partners.